Liu Y - Search Results

1

O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis.

Liu R, Gou D, Xiang J, Pan X, Gao Q, Zhou P, Liu Y, Hu J, Wang K, Tang N. Liu R, et al. Among authors: liu y. Oncogene. 2021 Dec;40(50):6707-6719. doi: 10.1038/s41388-021-02058-z. Epub 2021 Oct 14. Oncogene. 2021. PMID: 34650217 Free PMC article.

2

SARS-CoV-2 Vaccine Development: An Overview and Perspectives.

Liu Y, Wang K, Massoud TF, Paulmurugan R. Liu Y, et al. ACS Pharmacol Transl Sci. 2020 Sep 18;3(5):844-858. doi: 10.1021/acsptsci.0c00109. eCollection 2020 Oct 9. ACS Pharmacol Transl Sci. 2020. PMID: 33062951 Free PMC article. Review.

3

Depletion of VPS35 attenuates metastasis of hepatocellular carcinoma by restraining the Wnt/PCP signaling pathway.

Liu Y, Deng H, Liang L, Zhang G, Xia J, Ding K, Tang N, Wang K. Liu Y, et al. Genes Dis. 2020 Jul 25;8(2):232-240. doi: 10.1016/j.gendis.2020.07.009. eCollection 2021 Mar. Genes Dis. 2020. PMID: 33997170 Free PMC article.

4

The effects of estrogen on targeted cancer therapy drugs.

Zhao Y, Wang X, Liu Y, Wang HY, Xiang J. Zhao Y, et al. Among authors: liu y. Pharmacol Res. 2022 Mar;177:106131. doi: 10.1016/j.phrs.2022.106131. Epub 2022 Feb 12. Pharmacol Res. 2022. PMID: 35167895 Review.

5

O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma.

Zhou P, Chang WY, Gong DA, Huang LY, Liu R, Liu Y, Xia J, Wang K, Tang N, Huang AL. Zhou P, et al. Among authors: liu y, liu r. Oncogene. 2023 Mar;42(10):725-736. doi: 10.1038/s41388-022-02589-z. Epub 2023 Jan 5. Oncogene. 2023. PMID: 36604567

6

SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase.

Xu FL, Wu XH, Chen C, Wang K, Huang LY, Xia J, Liu Y, Shan XF, Tang N. Xu FL, et al. Among authors: liu y. Cell Death Dis. 2023 Jan 12;14(1):22. doi: 10.1038/s41419-023-05558-w. Cell Death Dis. 2023. PMID: 36635256 Free PMC article.

7

Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression.

Gou D, Liu R, Shan X, Deng H, Chen C, Xiang J, Liu Y, Gao Q, Li Z, Huang A, Wang K, Tang N. Gou D, et al. Among authors: liu y, liu r. J Clin Invest. 2023 Jul 3;133(13):e161713. doi: 10.1172/JCI161713. J Clin Invest. 2023. PMID: 37166978 Free PMC article.

8

High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate.

Zhou P, Chang WY, Gong DA, Xia J, Chen W, Huang LY, Liu R, Liu Y, Chen C, Wang K, Tang N, Huang AL. Zhou P, et al. Among authors: liu y, liu r. Cell Metab. 2023 Nov 7;35(11):1961-1975.e6. doi: 10.1016/j.cmet.2023.09.009. Epub 2023 Oct 4. Cell Metab. 2023. PMID: 37797623

9

Loss of SLC27A5 Activates Hepatic Stellate Cells and Promotes Liver Fibrosis via Unconjugated Cholic Acid.

Wu K, Liu Y, Xia J, Liu J, Wang K, Liang H, Xu F, Liu D, Nie D, Tang X, Huang A, Chen C, Tang N. Wu K, et al. Among authors: liu j, liu y, liu d. Adv Sci (Weinh). 2024 Jan;11(2):e2304408. doi: 10.1002/advs.202304408. Epub 2023 Nov 13. Adv Sci (Weinh). 2024. PMID: 37957540 Free PMC article.

10

Metabolic Enzyme SLC27A5 Regulates PIP4K2A pre-mRNA Splicing as a Noncanonical Mechanism to Suppress Hepatocellular Carcinoma Metastasis.

Nie D, Tang X, Deng H, Yang X, Tao J, Xu F, Liu Y, Wu K, Wang K, Mei Z, Huang A, Tang N. Nie D, et al. Among authors: liu y. Adv Sci (Weinh). 2024 Feb;11(5):e2305374. doi: 10.1002/advs.202305374. Epub 2023 Dec 7. Adv Sci (Weinh). 2024. PMID: 38059827 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191,420 results

Search Page